Liposome-encapsulated ISMN: a novel nitric oxide-based therapeutic agent against Staphylococcus aureus biofilms.

PLoS One · 2014 · PMC3962386 · PMID 24658315

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the results did not reach statistical significance, ISMN-liposomal formulations showed stronger anti-biofilm effects than blank liposomes, especially at the higher ISMN dose.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.